Corcept Therapeutics, Inc. (CORT) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $78.86 -1.31%
EPS Growth %: -96.6%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -96.6%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q1 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $4.41 million versus the consensus estimate of $5.01 million.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
- Morgan Stanley Resumes Global Payments (GPN) at Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
